Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble Drugs
Open accessThe DOI matches its Crossref record; 181 of the 181 references it cites were found in a registry or an index.
Abstract
Oral administration is the most commonly used and readily accepted form of drug delivery; however, it is find that many drugs are difficult to attain enough bioavailability when administered via this route. Polymeric micelles (PMs) can overcome some limitations of the oral delivery acting as carriers able to enhance drug absorption, by providing (1) protection of the loaded drug from the harsh environment of the GI tract, (2) release of the drug in a controlled manner at target sites, (3) prolongation of the residence time in the gut by mucoadhesion, and (4) inhibition of efflux pumps to improve the drug accumulation. To explain the mechanisms for enhancement of oral bioavailability, we discussed the special stability of PMs, the controlled release properties of pH-sensitive PMs, the prolongation of residence time with mucoadhesive PMs, and the P-gp inhibitors commonly used in PMs, respectively. The primary purpose of this paper is to illustrate the potential of PMs for delivery of poorly water-soluble drugs with bioavailability being well maintained.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Schematic representation of the mechanisms involved in the absorption of exogenous drugs in the small intestine. (a) Transcellular transport; (b) active transport; (c) facilitated diffusion; (d) receptor-mediated endocytosis; (e) paracellular transport; (f) pinocytosis [3].](https://figures.cochat.ai/paper-figures/f760f35972f34f1c8e324112b058d11c/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-1.jpg)


![Figure 4 Pluronic block copolymers available from BASF (Wyandotte, MI, USA) contain two hydrophilic EO blocks and a hydrophobic PO block [167].](https://figures.cochat.ai/paper-figures/292163f5bd3e4a15b3eb9e18032f118f/polymeric-micelles-a-promising-drug-delivery-system-to-enhance-bioavailability-figure-4.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
ABC Transporters: From Microorganisms to Man
Higgins, C. F. (1992) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.08.110192.000435 · Cited by 3,985 · cited 3×
“Pgp is a 170-kDa membrane transporter which is part of the ATP-binding cassette (ABC) [150].”
BackgroundSolid lipid nanoparticles (SLN) for controlled drug delivery â a review of the state of the art
Müller, R. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00087-4 · Cited by 3,759 · cited 2×
“Several strategies have been proposed such as micronization, complexation, formation of solid solutions, microemulsification, and novel drug delivery systems, including nanoparticles, lipid-based vesicles, and micelles [15–18].”
BackgroundDrug-like properties and the causes of poor solubility and poor permeability
Lipinski, C. A. (2000) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/s1056-8719(00)00107-6 · Cited by 3,734 · cited 1×
“Besides, approximately 40% of currently marketed immediate-release oral drugs are considered practically insoluble (solubility less than 100 μg/mL) in water [6, 7].”
BackgroundImpact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348 · cited 2×
“macromolecules [12, 13].”
A review of stimuli-responsive nanocarriers for drug and gene delivery
Ganta, S., Devalapally, H., Shahiwala, A., & Amiji, M. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.12.017 · Cited by 2,155 · cited 2×
“Blends of this polymer with polyethylacrylate (PMAA-PEA) and polymethacrylate (PMAA-PMA) can be tailored to dissolve in specific pH ranges corresponding to specific locations in the GI tract [100–102].”
BackgroundMicellization of block copolymers
Riess, G. (2003) · Progress in Polymer Science · doi:10.1016/s0079-6700(03)00015-7 · Cited by 1,953 · cited 1×
“PMs are self-assembled core-shell nanostructures formed in an aqueous solution consisting of amphiphilic block copolymers (see Figure 2) [35, 36].”
BackgroundMucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
Lai, S. K., Wang, Y.-Y., & Hanes, J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.11.002 · Cited by 1,815 · cited 1×
“Mucoadhesion can be obtained by the building of either nonspecific interactions with the mucosal surface, such as covalent bonds, ionic bonds, hydrogen bonding, and van der Waals’ interactions [117], or specific interactions by functionalizing polymers with targeting ligands (e.”
BackgroundOral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers
Ensign, L. M., Cone, R., & Hanes, J. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,623 · cited 1×
“Intrinsic properties of drugs such as poor stability in the gastric environment, lowmucosal permeability, and low solubility in the mucosal fluids will contribute to low absorption [26, 27].”
BackgroundPluronic® block copolymers as novel polymer therapeutics for drug and gene delivery
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00009-3 · Cited by 1,474 · cited 3×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the”
BackgroundMethodCone, R. A. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.008 · Cited by 1,459 · cited 1×
“The luminal surface of mucosal tissues is protected by a highly viscoelastic layer [110], and the protective coatings rapidly remove foreign particles from the GI tract which probably lead to low bioavailability.”
BackgroundSalt formation to improve drug solubility
Serajuddin, A. T. M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.010 · Cited by 1,425 · cited 1×
“To overcome these barriers and achieve above-mentioned requirements, several strategies have been proposed including the reduction of drug particle size [31], salt formation [32], or prodrug synthesis [33].”
BackgroundSolubilizing Excipients in Oral and Injectable Formulations
Strickley, R. G. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000016235.32639.23 · Cited by 1,415 · cited 2×
“Several strategies have been proposed such as micronization, complexation, formation of solid solutions, microemulsification, and novel drug delivery systems, including nanoparticles, lipid-based vesicles, and micelles [15–18].”
BackgroundResponsive polymers in controlled drug delivery
Bajpai, A. K., Shukla, S. K., Bhanu, S., & Kankane, S. (2008) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2008.07.005 · Cited by 1,391 · cited 2×
“[102] A.”
BackgroundGee, G. (1972) · Polymer · doi:10.1016/0032-3861(72)90025-0 · Cited by 1,360
Nano-engineering block copolymer aggregates for drug delivery
Allen, C., Maysinger, D., & Eisenberg, A. (1999) · Colloids and Surfaces B: Biointerfaces · doi:10.1016/s0927-7765(99)00058-2 · Cited by 1,358 · cited 1×
“For oral drug delivery system, the block copolymers used to form micelles should (1) spontaneously self-assemble in water, (2) enhance drug solubility by several orders of magnitude and provide high loading efficiency, (3) remain stable upon dilution in the GI tract, (4) be biocompatible and nontoxic, and (5) be easy…”
BackgroundNanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
Poly(styrene-ethylene oxide) block copolymer micelle formation in water: a fluorescence probe study
Wilhelm, M., Zhao, C. L., Wang, Y., Xu, R., Winnik, M. A., Mura, J. L., Riess, G., & Croucher, M. D. (1991) · Macromolecules · doi:10.1021/ma00005a010 · Cited by 1,276 · cited 2×
“[78] M.”
BackgroundPolymeric micelles—A new generation of colloidal drug carriers
Jones, M.-C., & Leroux, J.-C. (1999) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(99)00039-9 · Cited by 1,256 · cited 1×
“PMs are self-assembled core-shell nanostructures formed in an aqueous solution consisting of amphiphilic block copolymers (see Figure 2) [35, 36].”
BackgroundThe basics and underlying mechanisms of mucoadhesion
SMART, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.001 · Cited by 1,167
Amphiphilic block copolymers for drug delivery
Adams, M. L., Lavasanifar, A., & Kwon, G. S. (2003) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10397 · Cited by 1,078 · cited 1×
“These CMC values are much smaller than those of micelles formed from low-molecular weight surfactants (10–10M) [81], which allows a series of dilution and still retain the micellar structure.”
BackgroundPhysical stimuli-responsive polymeric micelles for anti-cancer drug delivery
Rapoport, N. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.009 · Cited by 1,002 · cited 2×
“[76] N.”
BackgroundThe use of mucoadhesive polymers in ocular drug delivery
LUDWIG, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.005 · Cited by 922 · cited 2×
“Mucoadhesion is a complex phenomenon, and several steps have been suggested in mucoadhesive bond formation [116].”
BackgroundTargeted delivery of low molecular drugs using chitosan and its derivatives
Park, J. H., Saravanakumar, G., Kim, K., & Kwon, I. C. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.003 · Cited by 821 · cited 1×
“Therefore, a considerable number of studies have been conducted using positively charged polymers such as chitosan to increase residence time in the GI tract [121, 122].”
BackgroundPoly(ethylene oxide)-block-poly(l-amino acid) micelles for drug delivery
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00015-7 · Cited by 756 · cited 2×
“[13] A.”
Block copolymer micelles for delivery of gene and related compounds
Kakizawa, Y., & Kataoka, K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00017-0 · Cited by 738 · cited 2×
“Amphiphilic copolymers which constitute PMs are usually block copolymers [51, 52].”
BackgroundBae, Y., & Kataoka, K. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.016 · Cited by 669 · cited 1×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the”
BackgroundAdvances in Mucoadhesion and Mucoadhesive Polymers
Khutoryanskiy, V. V. (2011) · Macromolecular Bioscience · doi:10.1002/mabi.201000388 · Cited by 655 · cited 2×
“[129] V.”
BackgroundPluronic® block copolymers for overcoming drug resistance in cancer
Kabanov, A. V., Batrakova, E. V., & Alakhov, V. Y. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00047-9 · Cited by 636 · cited 1×
“Figure 4: Pluronic block copolymers available from BASF (Wyandotte, MI, USA) contain two hydrophilic EO blocks and a hydrophobic PO block [167].”
MethodDesign of biodegradable particles for protein delivery
Vila, A., Sánchez, A., Tobı́o, M., Calvo, P., & Alonso, M. J. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00486-2 · Cited by 620 · cited 1×
“For example, PMs with appropriate particle size can be taken up and then cross the intestinal barrier [40, 70, 71].”
BackgroundPolymeric micelle for tumor pH and folate-mediated targeting
Lee, E. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00239-6 · Cited by 618 · cited 1×
“Many examples of “protonation” approaches to trigger destabilization of micelles have been reported, such as incorporating Lhistidine [97, 98], pyridine, and tertiary amine groups [99] in their hydrophobic segments.”
BackgroundVitamin E TPGS as a molecular biomaterial for drug delivery
Zhang, Z., Tan, S., & Feng, S.-S. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.046 · Cited by 586 · cited 14×
“Furthermore, its unique physicochemical properties (high water solubility, high flexibility, and large exclusion volume) provide good “stealth” properties for PMs [65, 66], while poly(N-vinyl-2-pyrrolidone) (PVP) [67] and poly(acrylic acid) (PAA) [68] are frequently used as PEG alternatives.”
BackgroundInfluentialDrug Nanoparticles: Formulating Poorly Water-Soluble Compounds
Merisko-Liversidge, E. M., & Liversidge, G. G. (2008) · Toxicologic Pathology · doi:10.1177/0192623307310946 · Cited by 579 · cited 2×
“[7] E.”
BackgroundPolymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs
Lu, Y., & Park, K. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.042 · Cited by 572 · cited 2×
“Meanwhile, the high drug loading of pharmaceutical products often makes it difficult to complete the study [11].”
BackgroundProdrug strategies to overcome poor water solubility
Stella, V. J., & Nti-Addae, K. W. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.05.013 · Cited by 554 · cited 2×
“To overcome these barriers and achieve above-mentioned requirements, several strategies have been proposed including the reduction of drug particle size [31], salt formation [32], or prodrug synthesis [33].”
BackgroundThe applications of Vitamin E TPGS in drug delivery
Guo, Y., Luo, J., Tan, S., Otieno, B. O., & Zhang, Z. (2013) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2013.02.006 · Cited by 523 · cited 1×
“Therefore, it has advantages over PEG and Vitamin E in application of various drug delivery device, including extending the half-life of the drug in plasma and enhancing the cellular uptake [169].”
BackgroundEffects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers
Rege, B. D., Kao, J. P. Y., & Polli, J. E. (2002) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(02)00055-6 · Cited by 509 · cited 2×
“Contrary to other surfactants, TPGS seems to have only a minor effect on membrane fluidity [173], challenging earlier reports [159].”
BackgroundResultPolymeric Micelles for Delivery of Poorly Water-Soluble Compounds
Kwon, G. S. (2003) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v20.i5.20 · Cited by 502
Ponchel, G. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00040-4 · Cited by 494
Rijcken, C. J. F., Soga, O., Hennink, W. E., & Nostrum, C. F. V. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.03.023 · Cited by 487 · cited 1×
“The physicochemical characteristics of the building blocks influence the physical and biological properties of the PMs [55].”
BackgroundBiodegradable polymer nanoparticles that rapidly penetrate the human mucus barrier
Tang, B. C., Dawson, M., Lai, S. K., Wang, Y.-Y., Suk, J. S., Yang, M., Zeitlin, P., Boyle, M. P., Fu, J., & Hanes, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905998106 · Cited by 453 · cited 1×
“Drugs delivered to mucosal surfaces are usually efficiently removed by mucus clearance mechanisms [109].”
BackgroundPoly(l-histidine)–PEG block copolymer micelles and pH-induced destabilization
Lee, E. S., Shin, H. J., Na, K., & Bae, Y. H. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00205-0 · Cited by 451 · cited 1×
“Many examples of “protonation” approaches to trigger destabilization of micelles have been reported, such as incorporating Lhistidine [97, 98], pyridine, and tertiary amine groups [99] in their hydrophobic segments.”
BackgroundBae, Y., Jang, W.-D., Nishiyama, N., Fukushima, S., & Kataoka, K. (2005) · Molecular BioSystems · doi:10.1039/b500266d · Cited by 445 · cited 2×
“To reach the absorption window, PMs can bemanipulated by coupling different types of polymers or by grafting various functional groups at the hydrophilic end of the copolymer, such as the pH-sensitive [72–74] and receptor sensitive groups [75].”
BackgroundThe Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
Shugarts, S., & Benet, L. Z. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9924-0 · Cited by 438 · cited 1×
“Based on that, the Biopharmaceutic Classification System (BCS) defines four categories of drugs [5].”
Characterization of Nanoparticles for Therapeutics
Hall, J. B., Dobrovolskaia, M. A., Patri, A. K., & McNeil, S. E. (2007) · Nanomedicine · doi:10.2217/17435889.2.6.789 · Cited by 409 · cited 1×
“In recent years, nanotechnology has been widely focused on by numbers of researchers throughout the world for its superiority in increasing efficacy, specificity, tolerability, and therapeutic index of corresponding drugs [14].”
BackgroundPolymeric micelles for oral drug delivery
Gaucher, G., Satturwar, P., Jones, M.-C., Furtos, A., & Leroux, J.-C. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.007 · Cited by 389 · cited 4×
“There exist many pathways for nutrient absorption in the small intestine; however, the absorption of oral drugs is restricted to either transport through the cells (transcellular pathway, see Figure 1(a)) or between adjacent cells (paracellular pathway, see Figure 1(e)) [3].”
BackgroundInfluentialIn vitro assessment of oral lipid based formulations
Porter, C. J. H., & Charman, W. N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00182-x · Cited by 389
Deli, M. A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.016 · Cited by 385 · cited 1×
“A drug that is administered orally must survive transit through the chemical and enzymatic GI liquids, cross the mucus layer and the epithelium before being absorbed [24, 25].”
BackgroundChen, W., Zhong, P., Meng, F., Cheng, R., Deng, C., Feijen, J., & Zhong, Z. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.01.001 · Cited by 363 · cited 1×
“This is also true for surfactant micelles which have been found in some cases to impede the absorption of hydrophobic drugs due to excessive retention in the micellar phase [85].”
BackgroundTargeted drug delivery via folate receptors
Zhao, X., Li, H., & Lee, R. J. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.3.309 · Cited by 358 · cited 1×
“To reach the absorption window, PMs can bemanipulated by coupling different types of polymers or by grafting various functional groups at the hydrophilic end of the copolymer, such as the pH-sensitive [72–74] and receptor sensitive groups [75].”
BackgroundTAKEUCHI, H., THONGBORISUTE, J., MATSUI, Y., SUGIHARA, H., YAMAMOTO, H., & KAWASHIMA, Y. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.07.008 · Cited by 354 · cited 1×
“Therefore, a considerable number of studies have been conducted using positively charged polymers such as chitosan to increase residence time in the GI tract [121, 122].”
BackgroundRuan, G., & Feng, S.-S. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00419-8 · Cited by 348 · cited 4×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the commonly used core-forming blocks of PMs, and have…”
BackgroundInfluentialPolymer–drug conjugates: Origins, progress to date and future directions
Kopeček, J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.10.014 · Cited by 347
Giri, T. K., Thakur, A., Alexander, A., Ajazuddin, Badwaik, H., & Tripathi, D. K. (2012) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2012.07.004 · Cited by 338 · cited 1×
“Chitosan (CS), a linear amino polysaccharide composed of randomly distributed (1– 4) linked d-glucosamine and N-acetyl-d-glucosamine units, is a well-known naturally occurring cationic biopolymer, which has received increasing attention owed to its biocompatibility, nontoxicity, and low immunogenicity [130, 131].”
BackgroundHarel, Z., Harel, S., Shah, P. S., Wald, R., Perl, J., & Bell, C. M. (2013) · The American Journal of Medicine · doi:10.1016/j.amjmed.2012.08.016 · Cited by 322 · cited 1×
“Furthermore, they should not induce significant gastrointestinal toxicities, such as nausea, vomiting, loss of appetite, or diarrhea, that would limit continued oral administration or result in poor compliance [29, 30].”
BackgroundFate of polymeric nanocarriers for oral drug delivery
Plapied, L., Duhem, N., des Rieux, A., & Préat, V. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.12.005 · Cited by 320
Mixed micelles self-assembled from block copolymers for drug delivery
Ebrahim Attia, A. B., Ong, Z. Y., Hedrick, J. L., Lee, P. P., Ee, P. L. R., Hammond, P. T., & Yang, Y.-Y. (2011) · Current Opinion in Colloid & Interface Science · doi:10.1016/j.cocis.2010.10.003 · Cited by 315 · cited 2×
“[80] A.”
BackgroundMartin, G., & Jain, R. K. (1994) · PubMed · Cited by 309
Lectin-mediated drug delivery:
Lehr, C.-M. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00228-x · Cited by 308 · cited 1×
“Lectins are proteins or glycoproteins of nonimmunological origin which specifically recognize sugar molecules and therefore are capable of binding to glycosylated membrane components [143, 144].”
BackgroundMicroemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Moroto, Y., Kanaoka, E., Takahashi, K., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00049-4 · Cited by 306
Alakhov, V. Y., Moskaleva, E. Y., Batrakova, E. V., & Kabanov, A. V. (1996) · Bioconjugate Chemistry · doi:10.1021/bc950093n · Cited by 304 · cited 9×
“Furthermore, its unique physicochemical properties (high water solubility, high flexibility, and large exclusion volume) provide good “stealth” properties for PMs [65, 66], while poly(N-vinyl-2-pyrrolidone) (PVP) [67] and poly(acrylic acid) (PAA) [68] are frequently used as PEG alternatives.”
BackgroundMethodInfluentialBarrier Properties of Gastrointestinal Mucus to Nanoparticle Transport
Crater, J. S., & Carrier, R. L. (2010) · Macromolecular Bioscience · doi:10.1002/mabi.201000137 · Cited by 302
Metallosupramolecular approach toward functional coordination polymers
Dobrawa, R., & Würthner, F. (2005) · Journal of Polymer Science Part A: Polymer Chemistry · doi:10.1002/pola.20997 · Cited by 299 · cited 1×
“In addition, there have been reports of PMs formed by complexation via hydrogen bonding [45–47] as well as metal-ligand coordination interactions [48], both referred to as noncovalently connected micelles.”
BackgroundPreparation of micelle-forming polymer-drug conjugates
Yokoyama, M., Kwon, G. S., Okano, T., Sakurai, Y., Seto, T., & Kataoka, K. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00016a007 · Cited by 294 · cited 1×
“Ringsdorf in 1984 [19] and subsequently used by Kataoka in the early 1990s through the development of doxorubicin-conjugated block copolymer micelles [20].”
MethodSuzuki, H., & Sugiyama, Y. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00178-0 · Cited by 291 · cited 1×
“Although part of the absorption process occurs in the oral cavity and stomach due to the presence of salivary amylase and gastric protease (pepsin), the small intestine remains the major site for absorption [22].”
Backgroundvan der Lubben, I. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00231-3 · Cited by 280
Collnot, E.-M., Baldes, C., Wempe, M. F., Kappl, R., Hüttermann, J., Hyatt, J. A., Edgar, K. J., Schaefer, U. F., & Lehr, C.-M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp060121r · Cited by 280 · cited 2×
“Contrary to other surfactants, TPGS seems to have only a minor effect on membrane fluidity [173], challenging earlier reports [159].”
BackgroundResultPolymeric micelles in oral chemotherapy
Bromberg, L. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.01.018 · Cited by 264 · cited 2×
“In contrast to the intravenous administration, which probably results in toxic blood level after injection and sometimes an under concentration of the desired threshold towards the end of the dosing interval, oral chemotherapy can provide a prolonged and continuous exposure to a relatively lower and thus safer concent…”
BackgroundMicronization: A method of improving the bioavailability of poorly soluble drugs
Chaumeil, J. C. (1998) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.1998.20.3.485666 · Cited by 242 · cited 1×
“To overcome these barriers and achieve above-mentioned requirements, several strategies have been proposed including the reduction of drug particle size [31], salt formation [32], or prodrug synthesis [33].”
BackgroundChitosan and its derivatives—a promising non-viral vector for gene transfection
Guang Liu, W., & De Yao, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00144-x · Cited by 236 · cited 1×
“Moreover, among the existing cationic polymers, chitosan is an ideal candidate for oral DNA and protein delivery [133] due to its mucoadhesive properties and its ability to induce a transient opening of the tight junctions [134].”
BackgroundLo, Y.-L. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00163-9 · Cited by 233
Batrakova, E. V., Li, S., Elmquist, W. F., Miller, D. W., Alakhov, V. Y., & Kabanov, A. V. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2165 · Cited by 229
Human gastric emptying and colonic filling of solids characterized by a new method
Camilleri, M., Colemont, L. J., Phillips, S. F., Brown, M. L., Thomforde, G. M., Chapman, N., & Zinsmeister, A. R. (1989) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1989.257.2.g284 · Cited by 227 · cited 1×
“168min) in healthy human volunteers by monitoring the migration of a radio-labeled marker previously mixed in their meal [82].”
BackgroundPegylation: engineering improved pharmaceuticals for enhanced therapy
Molineux, G. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)80004-4 · Cited by 225 · cited 1×
“Furthermore, its unique physicochemical properties (high water solubility, high flexibility, and large exclusion volume) provide good “stealth” properties for PMs [65, 66], while poly(N-vinyl-2-pyrrolidone) (PVP) [67] and poly(acrylic acid) (PAA) [68] are frequently used as PEG alternatives.”
BackgroundCollnot, E.-M., Baldes, C., Schaefer, U. F., Edgar, K. J., Wempe, M. F., & Lehr, C.-M. (2010) · Molecular Pharmaceutics · doi:10.1021/mp900191s · Cited by 219 · cited 1×
“Further in vitro studies were carried out to investigate the mechanisms of P-gp inhibition using Caco-2 cells model [174].”
MethodpH-Sensitive Unimolecular Polymeric Micelles: Synthesis of a Novel Drug Carrier
Jones, M.-C., Ranger, M., & Leroux, J.-C. (2003) · Bioconjugate Chemistry · doi:10.1021/bc020041f · Cited by 216
Zhang, C., Qu, G., Sun, Y., Wu, X., Yao, Z., Guo, Q., Ding, Q., Yuan, S., Shen, Z., Ping, Q., et al. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2007.11.029 · Cited by 205 · cited 1×
“as hydrophilic moieties and octyl groups as hydrophobic moieties [179].”
BackgroundDabholkar, R. D., Sawant, R. M., Mongayt, D. A., Devarajan, P. V., & Torchilin, V. P. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.02.018 · Cited by 200
Endogenous lectins as targets for drug delivery
Yamazaki, N., Kojima, S., Bovin, N. V., André, S., Gabius, S., & Gabius, H.-J. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00071-5 · Cited by 200 · cited 2×
“, lectins) [118, 119] or reactive groups such as thiols [120].”
BackgroundTang, Y., Liu, S. Y., Armes, S. P., & Billingham, N. C. (2003) · Biomacromolecules · doi:10.1021/bm030026t · Cited by 199 · cited 1×
“Many examples of “protonation” approaches to trigger destabilization of micelles have been reported, such as incorporating Lhistidine [97, 98], pyridine, and tertiary amine groups [99] in their hydrophobic segments.”
BackgroundThe mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles
Mo, R., Jin, X., Li, N., Ju, C., Sun, M., Zhang, C., & Ping, Q. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.005 · Cited by 198
Self-assembled polymer nanostructures for delivery of anticancer therapeutics
Wiradharma, N., Zhang, Y., Venkataraman, S., Hedrick, J. L., & Yang, Y. Y. (2009) · Nano Today · doi:10.1016/j.nantod.2009.06.001 · Cited by 191 · cited 1×
“The CMC is influenced by the hydrophilic-lipophilic balance (HLB) of the block copolymer [79].”
BackgroundMicroemulsion formulation for enhanced absorption of poorly soluble drugs
Kawakami, K., Yoshikawa, T., Hayashi, T., Nishihara, Y., & Masuda, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00050-0 · Cited by 188 · cited 2×
“Several strategies have been proposed such as micronization, complexation, formation of solid solutions, microemulsification, and novel drug delivery systems, including nanoparticles, lipid-based vesicles, and micelles [15–18].”
BackgroundThe mucosal immune system at the gastrointestinal barrier
Schenk, M., & Mueller, C. (2008) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2007.11.002 · Cited by 181
Plant lectins: Targeting programmed cell death pathways as antitumor agents
Fu, L.-L., Zhou, C.-C., Yao, S., Yu, J.-Y., Liu, B., & Bao, J.-K. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.07.004 · Cited by 177 · cited 2×
“, lectins) [118, 119] or reactive groups such as thiols [120].”
BackgroundMasaoka, Y., Tanaka, Y., Kataoka, M., Sakuma, S., & Yamashita, S. (2006) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2006.06.004 · Cited by 177 · cited 1×
“…China 3 Institute of Biopharmaceuticals of Shandong Province, Jinan 250101, China Correspondence should be addressed to Peixue Ling; lpx@sdfmg.com Received 28 March 2013; Revised 4 June 2013; Accepted 11 June 2013 Academic Editor: Juan M. Irache Copyright © 2013 Wei Xu et al. This is an open…”
BackgroundOral insulin delivery: the potential of thiolated chitosan-insulin tablets on non-diabetic rats
Krauland, A. H., Guggi, D., & Bernkop-Schnürch, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.017 · Cited by 176 · cited 2×
“According to previous studies, mucoadhesive PAA and thiomers increase the residence time of insulin at the site of intestinal absorptive cells, thus enhancing its intestinal absorption [140–142].”
BackgroundInoue, T., Chen, G., Nakamae, K., & Hoffman, A. S. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00172-7 · Cited by 175
Yin, T., Wang, P., Li, J., Zheng, R., Zheng, B., Cheng, D., Li, R., Lai, J., & Shuai, X. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.02.067 · Cited by 172
Wang, F., Zhang, D., Zhang, Q., Chen, Y., Zheng, D., Hao, L., Duan, C., Jia, L., Liu, G., & Liu, Y. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.08.041 · Cited by 170
Role of cellular uptake in the reversal of multidrug resistance by PEG-b-PLA polymeric micelles
Xiao, L., Xiong, X., Sun, X., Zhu, Y., Yang, H., Chen, H., Gan, L., Xu, H., & Yang, X. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.071 · Cited by 169 · cited 1×
“In addition, some other amphiphilic polymers have been reported as P-gp inhibitors, such as mPEG-block-polycaprolactone [175], PEG-phosphatidylethanolamine [172], PEG-bPLA [176], mPEG-poly(caprolactone-trimethylene carbonate) [177], and N-octyl-O-sulfate chitosan [178].”
BackgroundArsenic–glutathione conjugate transport by the human multidrug resistance proteins (MRPs/ABCCs)
Leslie, E. M. (2011) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2011.11.009 · Cited by 166 · cited 1×
“Moreover, Pluronic copolymers may inhibit the activity of drug efflux transporters such as P-gp, MRPs, and BCRP [163, 164], which make it an adequate strategy to increase the bioavailability and promote the efficacy of PTX.”
BackgroundNishiyama, N., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00314-5 · Cited by 163
Lee, H., Ahn, C., & Park, T. G. (2009) · Macromolecular Bioscience · doi:10.1002/mabi.200800229 · Cited by 163 · cited 1×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the”
BackgroundSant, V. P., Smith, D., & Leroux, J.-C. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.026 · Cited by 161 · cited 2×
“prepared and characterized a pH-sensitive PMs incorporating poorly water-soluble model drugs [104].”
BackgroundCombined cancer therapy by micellar-encapsulated drug and ultrasound
Rapoport, N. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2003.09.048 · Cited by 159 · cited 2×
“Poly(propylene oxide) (PPO) [53, 59] which belongs to Pluronics, poly(esters) such as poly(lactic acid) (PLA) [60], hydrophobic poly(amino acids) [61], copolymers of lactic acid and glycolic acids [62, 63], and poly(caprolactone) (PCL) [64], which are regarded as the commonly used core-forming blocks of PMs, and have…”
BackgroundBenahmed, A., Ranger, M., & Leroux, J. (2001) · Pharmaceutical Research · doi:10.1023/a:1011054930439 · Cited by 153
Yokoyama, M. (2011) · Journal of Experimental & Clinical Medicine · doi:10.1016/j.jecm.2011.06.002 · Cited by 152 · cited 1×
“Most drug carrier applications have been studied with A-B or A-B-A type block copolymers due to the close relationship between the properties of micelles and the structure of polymers [54].”
BackgroundYao, H.-J., Ju, R.-J., Wang, X., Zhang, Y., Li, R., Yu, Y., Zhang, L., & Lü, W.-L. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.01.038 · Cited by 151 · cited 11×
“In addition, PTX-containing PEG-PE/TPGS micelles were stable in vitro under various conditions, in particular, at low pH values and in the presence of bile acids, which is especially important for oral administration.”
BackgroundInfluentialSant, V. P., Smith, D. C., & Leroux, J. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.02.010 · Cited by 147
(1992) · PubMed · Cited by 140
Lavasanifar, A., Samuel, J., & Kwon, G. S. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00477-1 · Cited by 139
Arangoa, M. A., Campanero, M. Á., Renedo, M. J., Ponchel, G., & Irache, J. M. (2001) · Pharmaceutical Research · doi:10.1023/a:1013018111829 · Cited by 138 · cited 1×
“It was demonstrated that there exists a direct relationship between mucoadhesion and drug absorption [114, 115].”
BackgroundMakhlof, A., Werle, M., Tozuka, Y., & Takeuchi, H. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.02.001 · Cited by 137
Thermo-sensitive alginate-based injectable hydrogel for tissue engineering
Tan, R., She, Z., Wang, M., Fang, Z., Liu, Y., & Feng, Q. (2011) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2011.09.048 · Cited by 135 · cited 1×
“External factors such as heat [86, 87], light [88], and sound (ultrasound) [89, 90] have already been studied bymany researchers.”
BackgroundGao, Z. G., Lee, D. H., Kim, D. I., & Bae, Y. H. (2005) · Journal of Drug Targeting · doi:10.1080/10611860500376741 · Cited by 133 · cited 2×
“To reach the absorption window, PMs can bemanipulated by coupling different types of polymers or by grafting various functional groups at the hydrophilic end of the copolymer, such as the pH-sensitive [72–74] and receptor sensitive groups [75].”
BackgroundBioadhesive potential of gliadin nanoparticulate systems
Arangoa, M. A., Ponchel, G., Orecchioni, A. M., Renedo, M. J., Duchêne, D., & Irache, J. M. (2000) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(00)00121-4 · Cited by 129 · cited 1×
“It was demonstrated that there exists a direct relationship between mucoadhesion and drug absorption [114, 115].”
BackgroundHydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxel
Kim, S., Kim, J. Y., Huh, K. M., Acharya, G., & Park, K. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.07.004 · Cited by 126
Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa
Dünnhaupt, S., Barthelmes, J., Hombach, J., Sakloetsakun, D., Arkhipova, V., & Bernkop‐Schnürch, A. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.01.060 · Cited by 124 · cited 2×
“[127] S.”
BackgroundZhang, Z., Lee, S. H., Gan, C. W., & Feng, S. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9611-6 · Cited by 122 · cited 11×
“In addition, PTX-containing PEG-PE/TPGS micelles were stable in vitro under various conditions, in particular, at low pH values and in the presence of bile acids, which is especially important for oral administration.”
BackgroundInfluentialThe effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers*
Chang, T., Benet, L. Z., & Hebert, M. F. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80007-5 · Cited by 121
Bioadhesive properties and rheology of polyether-modified poly(acrylic acid) hydrogels
Bromberg, L. E., Temchenko, M., Alakhov, V. Y., & Hatton, T. A. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.030 · Cited by 120 · cited 1×
“Strong mucoadhesive properties of the Pluronic-PAA copolymers originate from both the carboxyl-mucin interactions and the ability of the polyether segments to interpenetrate into and anchor the copolymer on the mucosa [124].”
BackgroundBioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion
Repka, M. A., & McGinity, J. W. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00365-5 · Cited by 118 · cited 2×
“Other synthetic mucoadhesive polymers have been currently investigated in pharmaceutical formulations including PEG, cellulose derivatives (methylcellulose) [137, 138] and hydroxypropyl cellulose (HPC) [139], and polyelectrolytes (PAA) [39].”
BackgroundInfluentialLi, Y., & Kwon, G. S. (2000) · Pharmaceutical Research · doi:10.1023/a:1007529218802 · Cited by 117 · cited 1×
“Other methods used are direct dissolution [39], complexation [40], chemical conjugation [41], and various solvent evaporation procedures [42].”
MethodStabilized micelles as delivery vehicles for paclitaxel
Yoncheva, K., Calleja, P., Agüeros, M., Petrov, P. D., Miladinova, I., Tsvetanov, C. B., & Irache, J. M. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.06.030 · Cited by 112 · cited 2×
“once prepared, characterized, and evaluated the pharmacokinetics of PTX incorporated in stabilized Pluronic micelles [49].”
BackgroundMethodSolubilization of cyclosporin A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles
Francis, M. F., Lavoie, L., Winnik, F. M., & Leroux, J. (2003) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(03)00111-5 · Cited by 110 · cited 2×
“Amphiphilic copolymers which constitute PMs are usually block copolymers [51, 52].”
BackgroundZastre, J. A., Jackson, J. K., Bajwa, M. S., Liggins, R., Iqbal, F., & Burt, H. M. (2002) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(02)00119-4 · Cited by 109 · cited 1×
“In addition, some other amphiphilic polymers have been reported as P-gp inhibitors, such as mPEG-block-polycaprolactone [175], PEG-phosphatidylethanolamine [172], PEG-bPLA [176], mPEG-poly(caprolactone-trimethylene carbonate) [177], and N-octyl-O-sulfate chitosan [178].”
BackgroundEffect of pluronic F68 block copolymer on P-glycoprotein transport and CYP3A4 metabolism
Huang, J., Si, L., Jiang, L., Fan, Z., Qiu, J., & Gao, L. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2007.12.028 · Cited by 106 · cited 1×
“Moreover, Pluronic copolymers may inhibit the activity of drug efflux transporters such as P-gp, MRPs, and BCRP [163, 164], which make it an adequate strategy to increase the bioavailability and promote the efficacy of PTX.”
BackgroundIntestinal uptake and biodistribution of novel polymeric micelles after oral administration
Mathot, F., van Beijsterveldt, L., Véronique Préat, A., Brewster, M. E., & Ariën, A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.012 · Cited by 106 · cited 1×
“In addition, some other amphiphilic polymers have been reported as P-gp inhibitors, such as mPEG-block-polycaprolactone [175], PEG-phosphatidylethanolamine [172], PEG-bPLA [176], mPEG-poly(caprolactone-trimethylene carbonate) [177], and N-octyl-O-sulfate chitosan [178].”
BackgroundNa, J. H., Lee, S. Y., Lee, S., Koo, H., Min, K. H., Jeong, S. Y., Yuk, S. H., Kim, K., & Kwon, I. C. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.07.028 · Cited by 105 · cited 1×
“Therefore, water-soluble chitosan derivatives have often been used for development of drug delivery systems like glycol chitosan (GC) and chitosan oligosaccharide (CSO), exhibiting good solubility over a broad range of pH [135, 136].”
BackgroundPoly(lactide)‐poly(ethylene glycol) micelles as a carrier for griseofulvin
Pierri, E., & Avgoustakis, K. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30490 · Cited by 103 · cited 1×
“Several PMs systems designed to increase the oral bioavailability of hydrophobic compounds exhibit release times which largely exceeded the transit time in the small intestine [83, 84].”
BackgroundKim, T. G., Lee, H., Jang, Y., & Park, T. G. (2009) · Biomacromolecules · doi:10.1021/bm900116r · Cited by 98
Ould-Ouali, L., Noppe, M., Langlois, X., Willems, B., Riele, P. T., Timmerman, P., Brewster, M. E., Ariën, A., & Véronique Préat, A. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.10.022 · Cited by 98 · cited 1×
“Several PMs systems designed to increase the oral bioavailability of hydrophobic compounds exhibit release times which largely exceeded the transit time in the small intestine [83, 84].”
BackgroundSystemic heparin delivery by the pulmonary route using chitosan and glycol chitosan nanoparticles
Trapani, A., Gioia, S. D., Ditaranto, N., Cioffi, N., Goycoolea, F. M., Carbone, A., García-Fuentes, M., Conese, M., & Alonso, M. J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.02.035 · Cited by 95 · cited 1×
“Therefore, water-soluble chitosan derivatives have often been used for development of drug delivery systems like glycol chitosan (GC) and chitosan oligosaccharide (CSO), exhibiting good solubility over a broad range of pH [135, 136].”
BackgroundMeier, M. A. R., Aerts, S. N. H., Staal, B. B. P., Rasa, M., & Schubert, U. S. (2005) · Macromolecular Rapid Communications · doi:10.1002/marc.200500591 · Cited by 92
Ding, J., He, R., Zhou, G., Tang, C., & Yin, C. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2012.06.027 · Cited by 92 · cited 2×
“According to previous studies, mucoadhesive PAA and thiomers increase the residence time of insulin at the site of intestinal absorptive cells, thus enhancing its intestinal absorption [140–142].”
BackgroundNieto-Montesinos, R., Béduneau, A., Pellequer, Y., & Lamprecht, A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.034 · Cited by 90
Wei, Z., Yuan, S., Hao, J., & Fang, X. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.09.014 · Cited by 88 · cited 1×
“Pluronic block copolymers are known to induce drastic changes in the microviscosity of cell membranes, and these changes can be attributed to the alterations in the structure of the lipid bilayers as a result of absorption of the block copolymer molecules on the membranes [162].”
BackgroundEngineering strategies to enhance nanoparticle-mediated oral delivery
Yamanaka, Y. J., & Leong, K. W. (2008) · Journal of Biomaterials Science Polymer Edition · doi:10.1163/156856208786440479 · Cited by 87 · cited 1×
“For example, PMs with appropriate particle size can be taken up and then cross the intestinal barrier [40, 70, 71].”
BackgroundAnalysis of Upper Gastrointestinal Adverse Events Among Patients Given Dabigatran in the RE-LY Trial
Bytzer, P. M., Connolly, S. J., Yang, S., Ezekowitz, M. D., Formella, S., Reilly, P. A., & Aisenberg, J. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.10.021 · Cited by 85 · cited 1×
“Furthermore, they should not induce significant gastrointestinal toxicities, such as nausea, vomiting, loss of appetite, or diarrhea, that would limit continued oral administration or result in poor compliance [29, 30].”
BackgroundRegulation of the intestinal epithelial paracellular barrier
Daugherty, A. L., & Mrsny, R. J. (1999) · Pharmaceutical Science & Technology Today · doi:10.1016/s1461-5347(99)00170-4 · Cited by 80 · cited 1×
“On the contrary, hydrophilicmolecules cannot freely diffuse through the intestinal membrane, due to their low affinity for the lipidic constituents [23].”
BackgroundVoets, I. K., de Keizer, A., Cohen Stuart, M. A., Justynska, J., & Schlaad, H. (2007) · Macromolecules · doi:10.1021/ma0614444 · Cited by 79
Satturwar, P. M., Nasser‐Eddine, M., Ravenelle, F., & Leroux, J. (2006) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2006.09.012 · Cited by 77 · cited 1×
“The self-association into welldefined micellar structure is facilitated by the hydrophobic nonionizable Al(M)A units, whereas the pH sensitivity is conferred by the carboxylic acid groups of theMAAmoieties [106].”
BackgroundKausar, H., Munagala, R., Bansal, S. S., Aqil, F., Vadhanam, M. V., & Gupta, R. C. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.01.008 · Cited by 75
Roger, E., Lagarce, F., Garcion, E., & Benoît, J. (2010) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2010.04.015 · Cited by 73 · cited 1×
“Compounds transported by P-gp include important anticancer drugs like Vinca alkaloids [152], anthracyclines [153], epipodophyllotoxins, and taxanes [154].”
BackgroundLei, Y., Tan, J., Wink, M., Ma, Y., Li, N., & Su, G. (2012) · Food Chemistry · doi:10.1016/j.foodchem.2012.09.059 · Cited by 70
Calderara, F., Hruška, Z., Hurtrez, G., Lerch, J., Nugay, T., & Riess, G. (1994) · Macromolecules · doi:10.1021/ma00083a020 · Cited by 69
Absorption-promoting effects of chitosan in airway and intestinal cell lines: A comparative study
Vllasaliu, D., Casettari, L., Fowler, R., Exposito-Harris, R., Garnett, M., Illum, L., & Stolnik, S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.012 · Cited by 67
Gao, W., Bai, Y., Chen, E., Li, Z., Han, B., Yang, W., & Zhou, Q. (2006) · Macromolecules · doi:10.1021/ma0603579 · Cited by 61 · cited 2×
“In addition, there have been reports of PMs formed by complexation via hydrogen bonding [45–47] as well as metal-ligand coordination interactions [48], both referred to as noncovalently connected micelles.”
BackgroundKuo, S., Tung, P., Lai, C., Jeong, K., & Chang, F. (2007) · Macromolecular Rapid Communications · doi:10.1002/marc.200700697 · Cited by 60
Investigating the acoustic release of doxorubicin from targeted micelles
Husseini, G. A., Velluto, D., Kherbeck, L., Pitt, W. G., Hubbell, J. A., & Christensen, D. A. (2012) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2012.05.025 · Cited by 60 · cited 1×
“External factors such as heat [86, 87], light [88], and sound (ultrasound) [89, 90] have already been studied bymany researchers.”
BackgroundWang, Y., Hao, J., Li, Y., Zhang, Z., Sha, X., Han, L., & Fang, X. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.013 · Cited by 59 · cited 1×
“Therefore, ATP depletion caused by the inhibition of the ATPase activity induced by the Pluronic copolymers has been proposed to be a reason for chemosensitization of these cells [165, 166].”
BackgroundChen, C., Jin, Q., Liu, G., Li, D., Wang, J., & Ji, J. (2012) · Polymer · doi:10.1016/j.polymer.2012.06.024 · Cited by 58 · cited 1×
“External factors such as heat [86, 87], light [88], and sound (ultrasound) [89, 90] have already been studied bymany researchers.”
BackgroundCuestas, M. L., Castillo, A. I., Sosnik, A., & Mathet, V. L. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.09.012 · Cited by 57
Thiol-Functionalized Polymeric Micelles: From Molecular Recognition to Improved Mucoadhesion
Dufresne, M.-H., Gauthier, M. A., & Leroux, J.-C. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050007b · Cited by 56
Gillessen, S., Gnad-Vogt, U. S., Gallerani, E., Beck, J., Sessa, C., Omlin, A., Mattiacci, M. R., Liedert, B., Kramer, D., Laurent, J., et al. (2013) · European Journal of Cancer · doi:10.1016/j.ejca.2012.07.015 · Cited by 54 · cited 1×
“To achieve the desired therapeutic concentration in the target sites, dose escalation study of the drug was often applied in clinic [9, 10].”
BackgroundSynthesis and pH-dependent micellization of diblock copolymer mixtures
Butsele, K. V., Sibret, P., Fustin, C., Gohy, J., Passirani, C., Benoît, J., Jérôme, R., & Jérôme, C. (2008) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2008.09.080 · Cited by 54 · cited 1×
“The typical methods used for encapsulation of poorly water-soluble drugs are dialysis method, oil-in-water emulsion solvent evaporation method, and solid dispersion method [37, 38].”
MethodChoi, Y. K., Poudel, B. K., Marasini, N., Yang, K. Y., Kim, J. W., Kim, J. O., Choi, H., & Yong, C. S. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.05.039 · Cited by 53
The use of thiolated polymers as carrier matrix in oral peptide delivery—Proof of concept
Bernkop‐Schnürch, A., Pinter, Y., Guggi, D., Kahlbacher, H., Schöffmann, G., Schuh, M., Schmerold, I., Curto, M. D. D., D'Antonio, M., Esposito, P., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.04.004 · Cited by 53 · cited 2×
“Thiolated polymers also exhibit an increased permeation-enhancing effect as well as enzyme inhibitory properties [145].”
BackgroundPreparation and drug controlled-release of polyion complex micelles as drug delivery systems
Luo, Y., Yao, X., Yuan, J., Ding, T., & Gao, Q. (2008) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2008.10.014 · Cited by 52
Bioadhesive Properties of Poly(alkylcyanoacrylate) Nanoparticles Coated with Polysaccharide
Bertholon, I., Ponchel, G., Labarre, D., Couvreur, P., & Vauthier, C. (2006) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2006.418 · Cited by 51 · cited 1×
“electrostatic interactions with glycoproteins of mucus [132] are of primary interest for oral delivery and its cationic properties below pH 6.”
BackgroundThiomers: development and in vitro evaluation of a peroral microparticulate peptide delivery system
Krauland, A. H., & Bernkop‐Schnürch, A. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2003.09.011 · Cited by 49 · cited 2×
“According to previous studies, mucoadhesive PAA and thiomers increase the residence time of insulin at the site of intestinal absorptive cells, thus enhancing its intestinal absorption [140–142].”
BackgroundCharacterization of diacetylenic liposomes as carriers for oral vaccines
Alonso, S. D. V., Chiaramoni, N. S., Lioy, V. S., Gargini, R., Viera, L., & Taira, M. C. (2003) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(02)00190-1 · Cited by 49
Rahmat, D., Muller, C. R., Barthelmes, J., Shahnaz, G., Martien, R., & Bernkop‐Schnürch, A. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.10.008 · Cited by 47 · cited 1×
“Hence, it may be an effective means of increasing uptake of drugs with mucoadhesive PMs [111, 112], and there have been considerable interests in the concept of mucoadhesive PMs.”
BackgroundWu, S., & Hopkins, W. (1999) · Pharmaceutical technology · Cited by 47
Monjazeb, A. M., Ayala, D., Jensen, C. A., Case, L. D., Bourland, J. D., Ellis, T. L., McMullen, K. P., Chan, M. D., Tatter, S. B., Lesser, G. J., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.10.018 · Cited by 46 · cited 1×
“To achieve the desired therapeutic concentration in the target sites, dose escalation study of the drug was often applied in clinic [9, 10].”
BackgroundAggregation behavior of methacrylic acid/ethyl acrylate copolymer in dilute solutions
Dai, S., Tam, K. C., & Jenkins, D. (2000) · European Polymer Journal · doi:10.1016/s0014-3057(00)00022-7 · Cited by 44 · cited 2×
“[100] S.”
BackgroundOral Chemotherapeutic Delivery: Design and Cellular Response
Blanchette, J. O., & Peppas, N. A. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8973-8 · Cited by 43 · cited 2×
“Polymers such as cross-linked polyacrylic acids (PAA) [124–126], carboxypolymethylene, carboxymethyl cellulose, alginate, chitosan (CS), and their derivatives [127–129] are commonly accepted as mucoadhesive and safe polymers.”
BackgroundThiol-Functionalized Poly(ethylene glycol)-b-polyesters: Synthesis and Characterization
Kalarickal, N. C., Rimmer, S., Sarker, P. K., & Leroux, J. (2007) · Macromolecules · doi:10.1021/ma062377g · Cited by 43 · cited 1×
“While these micelles were initially designed to carry nucleic acid drugs, a similar strategy may be applied to deliver hydrophobic drugs through the use of thiol-functionalized PEG-b-PLA or PEGb-PCL PMs [147].”
BackgroundThrimawithana, T. R., Young, S. A., Bunt, C. R., Green, C. R., & Alany, R. G. (2011) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2011.08.026 · Cited by 41 · cited 1×
“Other synthetic mucoadhesive polymers have been currently investigated in pharmaceutical formulations including PEG, cellulose derivatives (methylcellulose) [137, 138] and hydroxypropyl cellulose (HPC) [139], and polyelectrolytes (PAA) [39].”
BackgroundReentrant Morphological Transitions in Copolymer Micelles with pH-Sensitive Corona
Borisov, O. V., & Zhulina, E. B. (2005) · Langmuir · doi:10.1021/la0469203 · Cited by 40 · cited 2×
“[96] O.”
BackgroundHsu, C.-H., Kuo, S., Chen, J.-K., Ko, F., Liao, C., & Chang, F. (2008) · Langmuir · doi:10.1021/la703960g · Cited by 38 · cited 2×
“[45] C.”
BackgroundLectin functionalized nanocarriers for gene delivery
Gajbhiye, V., & Gong, S. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.01.005 · Cited by 37 · cited 1×
“Lectins are proteins or glycoproteins of nonimmunological origin which specifically recognize sugar molecules and therefore are capable of binding to glycosylated membrane components [143, 144].”
BackgroundSrivalli, K. M. R., Lakshmi, P. K., & Balasubramaniam, J. (2012) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2012.01.004 · Cited by 35 · cited 1×
“Hence, it may be an effective means of increasing uptake of drugs with mucoadhesive PMs [111, 112], and there have been considerable interests in the concept of mucoadhesive PMs.”
BackgroundMcDowell, A., & McLeod, B. J. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.06.012 · Cited by 33
MÜLDER, H. S., Dekker, H., Pinedo, H. M., & Lankelma, J. (1995) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)00221-k · Cited by 33 · cited 1×
“Compounds transported by P-gp include important anticancer drugs like Vinca alkaloids [152], anthracyclines [153], epipodophyllotoxins, and taxanes [154].”
BackgroundPharmaceutical Micelles: Combining Longevity, Stability, and Stimuli Sensitivity
Carstens, M. G., Rijcken, C. J. F., van Nostrum, C. F., & Hennink, W. E. (2008) · Fundamental biomedical technologies · doi:10.1007/978-0-387-76554-9_9 · Cited by 31 · cited 1×
“The choice of coreforming polymers is the major determinant for important properties of PMs such as stability, drug loading capacity, and drug release profiles [58].”
BackgroundKetal containing amphiphilic block copolymer micelles as pH-sensitive drug carriers
Lee, I., Park, M., Kim, Y., Hwang, O., Khang, G., & Lee, D. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.03.017 · Cited by 31
Polymeric Micelles for the Targeting of Hydrophobic Drugs
Yokoyama, M. (2005) · Drugs and the pharmaceutical sciences · doi:10.1201/9780849348129.ch13 · Cited by 27 · cited 1×
“Lengths of the hydrophobic and hydrophilic blocks affect the conformation of polymers in medium, as lengthier hydrophilic blocks of polymer cause it to remain monomeric in water [50].”
BackgroundpH-responsive lipid core micelles for tumour targeting
Ravazzolo, E., Salmaso, S., Mastrotto, F., Bersani, S., Gallon, E., & Caliceti, P. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.11.002 · Cited by 24
Xu, Z., Guo, M., Yan, H., & Liu, K. (2013) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2012.12.012 · Cited by 23 · cited 2×
“[93] Z.”
BackgroundWater Soluble Polymers for Medicine
Kálal, J., Drobnik, J., Kopec̆ek, J., & Exner, J. (1978) · British Polymer Journal · doi:10.1002/pi.4980100204 · Cited by 23 · cited 1×
“Ringsdorf in 1984 [19] and subsequently used by Kataoka in the early 1990s through the development of doxorubicin-conjugated block copolymer micelles [20].”
MethodJin, M., Shimada, T., Yokogawa, K., Nomura, M., Ishizaki, J., Piao, Y., Kato, Y., Tsuji, A., & Miyamoto, K. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.020 · Cited by 23 · cited 1×
“Several drugs, including cyclosporine A (cyA) and verapamil, have been studied for this purpose [156, 157].”
BackgroundLiu, G., Li, X., Xiong, S., Li, L., Chu, P. K.-H., Yeung, K., Wu, S., & Xu, Z. (2011) · Colloid & Polymer Science · doi:10.1007/s00396-011-2558-x · Cited by 23
Cellular evaluation of oral chemotherapy carriers
Blanchette, J. O., & Peppas, N. A. (2005) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.30243 · Cited by 22 · cited 2×
“[125] J.”
BackgroundAle, E. C., Maggio, B., & Fanani, M. L. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.06.017 · Cited by 19 · cited 1×
“Due to their nanoscopic size, ability to solubilize hydrophobic drugs in large amounts and achieve site-specific delivery, PMs hold promise to obtain desirable biopharmaceutical and pharmacokinetic properties of drugs [21] and enhance their bioavailability.”
BackgroundLiu, G., Li, X., Xiong, S., Li, L., Chu, P. K.-H., Wu, S., & Xu, Z. (2011) · Journal of Fluorine Chemistry · doi:10.1016/j.jfluchem.2011.08.012 · Cited by 18
Honkanen, O., Marvola, J., Kanerva, H., Lindevall, K., Lipponen, M., Kekki, T., Ahonen, A. K., & Marvola, M. (2004) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2004.01.008 · Cited by 18 · cited 1×
“Other synthetic mucoadhesive polymers have been currently investigated in pharmaceutical formulations including PEG, cellulose derivatives (methylcellulose) [137, 138] and hydroxypropyl cellulose (HPC) [139], and polyelectrolytes (PAA) [39].”
BackgroundLi, G., Lin, D., Xie, X., Qin, L.-F., Wang, J.-T., & Liu, K. (2013) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(13)60007-2 · Cited by 14 · cited 1×
“Therefore, ATP depletion caused by the inhibition of the ATPase activity induced by the Pluronic copolymers has been proposed to be a reason for chemosensitization of these cells [165, 166].”
BackgroundRong, Z., Xu, Y., Zhang, C., Xiang, D., Li, X., & Liu, D. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.12.010 · Cited by 14 · cited 1×
“The extent of absorption for poorly water-soluble drugs (and orally administered drugs in general) is affected by these efflux pathways [148].”
BackgroundSynthesis and characterization of a new polymer–drug conjugate with pH-induced activity
Chang, H.-P., Chen, J., Zhong, P.-S., Chang, Y., & Liang, M. (2012) · Polymer · doi:10.1016/j.polymer.2012.06.006 · Cited by 12 · cited 1×
“Other types of pH-controlled release carriers such as pHsensitive polymer-drug conjugates [107, 108] are beyond the scope of PMs and not discussed in this review.”
BackgroundTaillefer (2000) · doi:10.1002/(sici)1520-6017(200001)89:1<52::aid-jps6>3.0.co;2-d · cited 1×
“The typical methods used for encapsulation of poorly water-soluble drugs are dialysis method, oil-in-water emulsion solvent evaporation method, and solid dispersion method [37, 38].”
Method
Research works printed but not linked: 2
- Lee ES Shin HJ Na K Bae YH Poly(L-histidine)-PEG block copolymer micelles and pH-induced destabilization Journal of Controlled Release 2003 90 3 363 374 2-s2.0-0038106270 12880703 · DOI · Paper page
- Mo R Jin X Li N The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles Biomaterials 2011 32 20 4609 4620 2-s2.0-79955522520 21440934 · DOI · Paper page
Cited by
Nano based drug delivery systems: recent developments and future prospects
Patra, J. K., Das, G., Fraceto, L. F., Campos, E. V. R., Rodriguez-Torres, M. D. P., Acosta-Torres, L. S., Diaz-Torres, L. A., Grillo, R., Swamy, M. K., Sharma, S., et al. (2018) · Journal of Nanobiotechnology · doi:10.1186/s12951-018-0392-8 · Cited by 6,684
Strategies to improve micelle stability for drug delivery
Lu, Y., Zhang, E., Yang, J., & Cao, Z. (2018) · Nano Research · doi:10.1007/s12274-018-2152-3 · Cited by 530
“In addition, the assembly of these long hydrophobic chains can barely achieve a thermodynamic equilibrium and is highly dependent on the specific method used to formulate the assembly [50].”
Emerging trends in the novel drug delivery approaches for the treatment of lung cancer
Sharma, P., Mehta, M., Dhanjal, D. S., Kaur, S., Gupta, G., Singh, H., Thangavelu, L., Rajeshkumar, S., Tambuwala, M., Bakshi, H. A., et al. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.06.033 · Cited by 430
Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview
Zhao, J., Yang, J., & Xie, Y. (2019) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2019.118642 · Cited by 421
Advances in Nanotechnology for Enhancing the Solubility and Bioavailability of Poorly Soluble Drugs
Liu, Y., Liang, Y., Yuhong, J., Xin, P., Han, J. L., Du, Y., Yu, X., Zhu, R., Zhang, M., Chen, W., et al. (2024) · Drug Design, Development and Therapy · doi:10.2147/dddt.s447496 · Cited by 365
Metadata
- Authors
- Xu, W., Ling, P., & Zhang, T.
- Affiliations
- Shandong University (CN)
- Institute of Biopharmaceuticals of Shandong Province, Jinan 250101, China
- Corresponding author
- Ling, Peixue
- ORCID
- Venue
- Journal of Drug Delivery
- Publisher
- Wiley
- Published
- 2013-06-27
- Volume
- 2013
- Pages
- 1-15
- ISSN
- 2090-3014 (ISSN-L)
- 2090-3022
- PMC
- PMC3712247
- OpenAlex
- W2061955697
- Cited by
- 595
- References
- 181
- Citations by year
- 2026: 32 · 2025: 47 · 2024: 50 · 2023: 60 · 2022: 74 · 2021: 70 · 2020: 56 · 2019: 49 · 2018: 41 · 2017: 43 · 2016: 32 · 2015: 22 · 2014: 18 · 2013: 1
- FWCI
- 14.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Journal of Drug Delivery (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of California, Davis
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Drug Solubulity and Delivery Systems
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- polymeric micelles, oral drug delivery, bioavailability enhancement, poorly water-soluble drugs, mucoadhesion, pH-responsive micelles, controlled drug release, P-glycoprotein inhibition, efflux pump inhibition, drug stability
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.